Literature DB >> 11454848

Strong prognostic value of combining N-terminal atrial natriuretic peptide and ECG to predict death in heart patients from general practice.

O W Nielsen, J Hilden, J F Hansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11454848      PMCID： PMC1729842          DOI： 10.1136/heart.86.2.218

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  26 in total

Review 1.  Epidemiology, aetiology, and prognosis of heart failure.

Authors:  J J McMurray; S Stewart
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests.

Authors:  O W Nielsen; J F Hansen; J Hilden; C T Larsen; J Svanegaard
Journal:  BMJ       Date:  2000-01-22

4.  Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries.

Authors:  C Berry; C A Hamilton; M J Brosnan; F G Magill; G A Berg; J J McMurray; A F Dominiczak
Journal:  Circulation       Date:  2000-05-09       Impact factor: 29.690

Review 5.  The taxanes: an update.

Authors:  J Crown; M O'Leary
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

6.  Biochemical detection of left-ventricular systolic dysfunction.

Authors:  T A McDonagh; S D Robb; D R Murdoch; J J Morton; I Ford; C E Morrison; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

7.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

8.  Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries.

Authors:  C Huraux; T Makita; S Kurz; K Yamaguchi; F Szlam; M M Tarpey; J N Wilcox; D G Harrison; J H Levy
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690

9.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

Authors:  M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton
Journal:  Lancet       Date:  1997-11-08       Impact factor: 79.321

10.  Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

Authors:  J Nolan; P D Batin; R Andrews; S J Lindsay; P Brooksby; M Mullen; W Baig; A D Flapan; A Cowley; R J Prescott; J M Neilson; K A Fox
Journal:  Circulation       Date:  1998-10-13       Impact factor: 29.690
View more
  3 in total

1.  The relationship between long-term changes in plasma B-type natriuretic peptide levels and electrocardiographic findings.

Authors:  Shinji Fukazawa; Koji Teruya; Takamoto Uemura; Tomoko Omine; Tomoko Matsui; Nobuo Takeda; Hiroteru Okamoto; Kaoru Ichikawa; Kosuke Tsuchida; Rieko Takemae; Momoo Matsuda; Tooru Tsunoda
Journal:  Environ Health Prev Med       Date:  2008-04-04       Impact factor: 3.674

2.  Survival differences between heart failure in general practices and in hospitals.

Authors:  O Wendelboe Nielsen; J Hilden; T McDonagh; J Fischer Hansen
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

3.  The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

Authors:  I Raymond; B A Groenning; P R Hildebrandt; J C Nilsson; M Baumann; J Trawinski; F Pedersen
Journal:  Heart       Date:  2003-07       Impact factor: 5.994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.